Amy W Schulman Buys $300K of Alnylam Pharmaceuticals Inc (ALNY) — SEC Form 4, Nov 12, 2026

Open-Market Net Purchase · SEC Form 4
+$299,526

Equity position changed by +7.9%

Reporting Owner
Director
TXN 2026-11-09 · FILED 2026-11-12
Equity Position 26K sh 24,049 → 25,959
Equity Change +7.9% shares held after vs before
Insider Cluster 2 buying within 30 days — view cluster
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Filing Date
2026-11-12
Report Date
2026-11-12
Accession No.
0001178670-26-000085
Accepted At
2026-11-12 21:01 UTC
Reporting Owner
Name Relationship
Amy W Schulman CIK 0001438226
Director
Amy W Schulman at Alnylam Pharmaceuticals Inc Full insider history
Bought (12 mo) $299,526
Sold (12 mo) —
More from this insider at Alnylam Pharmaceuticals Inc
2026-05-22 Award — View
2026-05-14 Exercise — View
2025-05-12 Award — View
2025-03-14 Exercise — View
2024-06-27 Sell -$2,040,000 View
All filings by this insider at Alnylam Pharmaceuticals Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2026-11-09 P - Purchase 1,910 A $156.82 +$299,526 25,959 Direct
5%+ Holders · 13D/G 6 filers
Other insiders at Alnylam Pharmaceuticals Inc
All Alnylam Pharmaceuticals Inc insider activity
GET /v1/forms/4/0001178670-26-000085 API docs
View Original SEC Filing